心脏起搏器

xīn zànɡ qǐ bó qì
  • pacemaker;cardiac pacemaker;heart pacemaker
心脏起搏器心脏起搏器
  1. 512例心脏起搏器的临床应用

    The clinical application with pacemaker implantation of 512 patients

  2. 这些有害事件包括神经刺激器出现意外“震荡”,胰岛素泵功能失常,心脏起搏器输出脉率的短暂改变等。

    Adverse events have included unintended " shocks " from neurostimulators , insulin pump malfunctions , and transient changes in pacemaker output pulse rate .

  3. 目的:探讨静脉注射盐酸普罗帕酮注射液对永久人工心脏起搏器心房、心室起搏阈值及心内电信号P波、R波振幅的影响。

    Objective : To observe the effects of propafenone hydrochloride injection on permanent heart pacing threshold and endocardial electrical signal amplitude .

  4. 多功能程控心脏起搏器电路系统的全CMOS单片集成技术

    Integration of all CMOS programmable pacemaker circuit system

  5. 开展了经皮冠状动脉介入诊疗、心脏起搏器植入术、运动负荷试验、CT冠状动脉三位成像、食道电生理等检查。

    Carried out percutaneous coronary intervention , pacemaker implantation , exercise stress test , CT coronary three imaging , such as esophageal electrophysiological examination .

  6. 根据QT间期优化双腔心脏起搏器房室延迟的探讨

    Optimal atrio-ventricular delay setting determined by QT interval measurement in patients with dual-chamber pacemakers

  7. 基于MSP430的微功耗体外临时心脏起搏器的设计

    On Design of Low Power Consumption External Temporary Heart Pacemaker On the Basis of MSP430

  8. 结论:留置永久性心脏起搏器并非TURP的绝对禁忌证,此类患者经过充分准备可以承受手术治疗。

    Conclusion : Patients with the permanent cardiac pacemaker can receive TURP .

  9. 目的探讨临时心脏起搏器治疗阿-斯综合征(ASS)的价值。

    Objective To explore the value of temporary cardiac pacemaker therapy on children with Adam-Stoke syndrome ( ASS ) .

  10. 目的探讨伴有缓慢型心律失常患者腹腔镜胆囊切除术(laparoscopiccholecystectomy,LC)中应用临时心脏起搏器的安全性。

    Objective To evaluate the safety of temporary cardiac pacemaker during perioperative period of laparoscopic cholecystectomy ( LC ) in patients with bradyarrhythmia .

  11. 方法:采用24h动态心电图对42例安装心脏起搏器患者进行随访,并与常规心电图检查结果相对比,分析起搏、感知及与起搏器相关的心律失常。

    Methods 42 patients were received 24-hour ambulatory electrocardiogram monitoring . Pacing or sensing abnormalities and pacemaker - related arrhythmias were analyzed .

  12. 方法对我科8例安装vvI型心脏起搏器后施行LC的临床资料进行分析。

    Methods The clinical data of 8 cases undergoing LC under the use of vvI cardiac pacemaker were analysed .

  13. MRI空间分辨率强无辐射,但由于不适于检查如心脏起搏器介入的心脏病患者而限制其应用。

    MRI has higher spatial resolution intensity without any radiation , but its application was limited because it is not suitable for checking heart disease patients who has underwent heart pacemaker intervention operation .

  14. 结果:在临时人工心脏起搏器的保护下91.6%的患者顺利完成麻醉及手术,43.1%的患者度过重症监护病房(ICU)的早期。

    Results : 91.6 % patients were anesthesiaed and operated under the protection of artificial cardiac pacemaker . And 43.1 % patients passed ICU early times .

  15. 目的研究肝素抗凝对经股静脉植入临时心脏起搏器深静脉血栓(DVT)的预防作用。

    Objective To discuss the preventive effect of anticoagulation heparin on deep venous thrombosis ( DVT ) associated with temporary transvenous pacemakers .

  16. 这种继电器用于ESD测试设备、电缆测试设备和心脏起搏器,是理想的电容器快速充电或放电的开关元件。

    These relays are ideal for high in-rush capacitive make and capacitive discharge loads found in ESD test equipment , cable test equipment and heart defibrillators .

  17. 结论RT-3DE对人工心脏起搏器安置术后患者的监测有肯定价值,为观察起搏电极在心腔的空间位置提供了新的视角。

    Conclusion RT-3DE has certain values for implanting permanent pacemaker and it provides a new vision .

  18. 关于VVS的治疗目前尚无定论,主要为药物治疗,还可用心脏起搏器治疗。

    In general , the available therapeutic options for WS are mainly pharmacological therapy and cardiac pacing .

  19. 基于MSP430系列单片机设计了体外临时心脏起搏器的起搏装置,给出了硬件设计电路和软件的系统结构。

    On the basis of SCM of MSP430 series , an external temporary heart pace making device , with corresponding hardware cir - cuit and software system , is designed .

  20. 方法采用SCL90症状自评量表、医学应对问卷,对70例心脏起搏器携带者进行调查并统计分析。

    Method SCL-90 , Medical Coping Modes Questionnaire were used to investigate 70 cases of cardiac pacemaker carriers with statistical analysis .

  21. 使用心脏起搏器的非起搏器依赖性患者在1.5T强度下安全进行胸外磁共振成像的策略:115次检查的前瞻性研究

    Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients : A prospective study with 115 examinations

  22. 方法4例Ⅲ°AVB患儿,男性3例,女性1例,年龄8~11岁,均经静脉植入VVI型永久性人工心脏起搏器。

    Methods The permanent artificial pacemaker ( pacing mode VVI ) were implanted by right subclavian vein in 4 children with ⅲ° AVB . Age : from 8 to 11 years .

  23. 方法对10例植入CPIDelta937型DDD心脏起搏器的患者,使用程序胸壁刺激试验(PCWS)测定起搏器对电干扰的反应。

    Methods The pacemaker response to interference were determined with programmed chest wall stimulation ( PCWS ) test in 10 patients with Model Delta 937 DDD pacemakers implanted .

  24. 心电图、心内电图及临床表现的特点符合Lev氏病,且都植入了永久心脏起搏器治疗。

    Surface ECG , intracardiac electrogram and clinical manifestation of 6 patients were identical to features of Lev ′ s disease . All patients had been implanted with a permanent cardiac pacemaker .

  25. 日常使用的增加物还包括心脏起搏器,内部心脏除颤器(ICDs)以及更为常见的假牙和硅胶乳房植入物等。

    Then there are pacemakers and internal cardiac defibrillators ( ICDs ) , as well as more common augmentations like dentures and silicone breast implants .

  26. 方法随机选择安装永久性心脏起搏器患者54例,根据起搏模式分为两组,其中VVI起搏器36例(V组),DDD起搏器18例(D组)。

    Methods 54 consecutive permanent cardiac pacing cases were randomly divided into two groups according to the pacing model . There were 36 patients with VVI pacemaker ( group V ) and 18 cases with DDD pacemaker ( group D ) .

  27. 结果:腹腔镜手术中安装心脏起搏器患者麻醉后10min、气腹后15min、超声刀应用后5min及手术后30min指标与手术前30min相比(1)心率、平均动脉压均增快及升高;

    Results : At 10 min after anaesth , 15 min after pneumoperitoneum , 5 min after harmonic scalpel , and 30 min after operation ( 1 ) compared with preoperation , HR and MAP were increased .

  28. 安置埋藏式心脏起搏器预防感染的措施

    Preventive measures for infections of the patients undergoing cardiac pacemaker implantation

  29. 单片集成智能化生理型心脏起搏器数字控制单元

    Monolithic Integrated Digital Unit of Intelligent Physiological ( DDD ) Pacemaker

  30. 安装人工永久心脏起搏器术后康复护理

    A study on rehabilitation nursing after given permanent artificial cardiac pacing